-
COVID-19 vaccines will not be mandatory: WHO
expresspharma
December 09, 2020
There may be some countries or some situations in countries where professional circumstances require it or highly recommend to be vaccinated.
-
Many Indians are sceptical of taking COVID-19 vaccine: LocalCircles survey
expresspharma
December 09, 2020
LocalCircles recently conducted a survey to gauge acceptance for COVID-19 vaccines in the country which reportedly received 25,000+ responses from citizens across 262 districts of India.
-
India likely to approve authorise COVID-19 vaccines in weeks
expresspharma
December 09, 2020
Government has identified 300 million people, including healthcare workers, policemen, and citizens above the age of 50, who would be administered a vaccine on a priority basis.
-
HSMD seeks update from government on Pfizer’s COVID-19 vaccine to prepare for distribution
expresspharma
December 09, 2020
The Hindustan Syringes and Medical Devices (HSMD) has written a letter to the Department of Health & Family Welfare requesting an update about the government’s action plans for Pfizer’s COVID-19 vaccine in India.
-
Hackers target COVID-19 vaccine cold chain, IBM finds
europeanpharmaceuticalreview
December 08, 2020
A group of hackers has sent phishing emails to various people involved in COVID-19 vaccine cold chain distribution to gain insight, IBM has revealed.
-
Sinovac get $515 mn funding for COVID-19 vaccine production
expresspharma
December 08, 2020
Sinovac said that it would be able to manufacture 300 million vaccine doses annually and aims to complete construction of a second production facility by the end of 2020 to increase annual COVID-19 vaccine production capacity to 600 million doses.
-
Johnson & Johnson announces initiation of rolling submission for its single-dose Janssen COVID-19 vaccine candidate with the European Medicines Agency
worldpharmanews
December 07, 2020
Janssen-Cilag International N.V., part of the Janssen Pharmaceutical Companies of Johnson & Johnson, has initiated a rolling submission with the European Medicines Agency (EMA) for its investigational single-dose vaccine candidate for the prevention ...
-
New Study Identifies Challenges for COVID-19 Vaccine Adoption
prnewswire
December 07, 2020
Advisory firm Avenue Group® conducted a series of one-on-one, in-depth phone interviews with doctors, nurses, and members of the general public to better understand what needs to happen in order for Americans to feel comfortable choosing to take a ...
-
NIAID study shows Moderna’s Covid-19 vaccine provides three-month immunity
pharmaceutical-technology
December 07, 2020
Researchers at the National Institute for Allergies and Infectious Diseases (NIAID) have reported that Moderna’s Covid-19 vaccine, mRNA-1273, caused the human immune system to produce potent antibodies that endure for at least three months.
-
Moderna to supply six million doses of COVID-19 vaccine to Israel
expresspharma
December 07, 2020
The company has already initiated the rolling regulatory review process with the Ministry of Health in Israel.